Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516341 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Nicholas Hall's Global Gastrointestinals Review

Nicholas Hall Group, July 2010, Pages: 306


  Description  
   Table of Contents   
   Products Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

This report focuses on core trends and exciting developments in the world’s leading GIs markets, providing the ultimate guide to this resilient OTC category, which posted 4% global growth for 2009 despite the recession.

Categories covered include Antacids & antiflatulents, Antidiarrhoeals, Antinauseants, Digestive enzymes, IBS remedies, Laxatives, Liver & bile remedies, traditional digestive remedies.

This essential report provides a strategic guide to the OTC Gastrointestinals market, exploring developments affecting GIs both globally and locally. The Gastrointestinals market is dynamic, having remained resilient throughout the recession, with growth consistently above or matching the global OTC average. Posting 4% global growth in 2009, GIs are set to maintain this dynamism as trends such as unhealthy diets, busy lifestyles and high stress levels continue to drive sales.

There are significant opportunities that marketers can capitalise on: GIs were successful 2005-09 despite limiting factors, which included lack of new product development and innovation across the majority of categories. With increased investment from OTC marketers, sales could soar, as consumers are demonstrably concerned about gut and digestive health.

There are some exciting developments, with probiotics driving growth in antidiarrhoeals and expanding into more niches. The entry of major marketers (such as P&G and Bayer) with high adspends has raised awareness, while media coverage continues to highlight the role probiotics can play in boosting metabolism and the immune system.

Antacids and antiflatulents face significant competition from generics and private labels, but the switch of PPIs in developed markets shows potential to revitalise the category. Laxatives are growing, partly through use as weight loss aids, but also through the rising popularity of osmotic options.

Analysing all of these key trends and developments impacting the global GIs market, the report assesses the situation across developed and emerging markets, with country profiles that include an overview of key trends, considered analysis by category, and an evaluation of future prospects. This report can be your guide to competing and succeeding in the global Gastrointestinals market.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds